Fluidigm Corporation v. BioMerieux, SA

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

FLUIDIGM CORPORATION, Case No. 19-CV-02716-LHK

Plaintiff,

ORDER GRANTING MOTION TO

DISMISS FOR LACK OF PERSONAL

v.

JURISDICTION WITH LEAVE TO

AMEND

BIOMERIEUX, SA, Re: Dkt. No. 21 Defendant. 17 bioMérieux SA (“Defendant”) moves to dismiss Fluidigm’s (“Plaintiff”) complaint for patent infringement of U.S. Patent No. 10,131,934 (the “’934 Patent”). Having considered the parties’ submissions, the relevant law, and the record in this case, the Court hereby GRANTS Defendant’s motion to dismiss with leave to amend. I. BACKGROUND A. Factual Background Plaintiff, a Delaware corporation with its principal place of business in San Francisco, California, owns the ’934 Patent, issued on November 20, 2018. ECF No. 1 ¶¶ 2, 12 (“Compl.”). The inventions claimed in the ’934 Patent broadly “pertain to methods for carrying out nucleic 27 1 amplification reactions and detecting polynucleotide sequences.” Id. ¶ 15. Plaintiff…